| Name | Title | Contact Details |
|---|
Enterin is pioneering the medical community`s understanding of the link between infections, dysfunction of the enteric nervous system (ENS) of the gut, and the early onset and chronic progression of neurodegenerative disease. We are leveraging years of research to become the first company in the world to develop a novel drug that repairs the dysfunctional gut-brain axis in patients with neurodegenerative disease. Our lead compound, ENT-01 (also known as kenterin), displaces membrane-bound alpha- synuclein (αS) aggregates from nerve cells in the ENS and improves neural signaling between the gut and the brain in preclinical models of Parkinson`s disease. In the gut, this results in improved motility. We are now progressing this drug through clinical trials in an attempt to reverse the constipation of Parkinson`s disease. Our long-term mission is to become the world leader in developing pharmaceutical therapies that repair the gut-brain axis.
PetDx® – The Liquid Biopsy Company for Pets™ is a molecular diagnostics company dedicated to unleashing the power of genomics to improve pet health.
Vascular Solutions, Inc. (Vascular), incorporated in December 1996, is a medical device company focused on bringing clinically advanced solutions to interventional cardiologists and interventional radiologists worldwide.
Stereotaxis, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Saint Louis, MO. To find more information about Stereotaxis, Inc., please visit www.stereotaxis.com
AssuraMed is a nationwide leader in medical supply distribution both for home delivery and wholesale for diabetes, ostomy, wound care, urological, incontinence, respiratory and other chronic conditions.